BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1117063)

  • 1. Appearance of hCG in pregnancy plasma following the initiation of implantation of the blastocyst.
    Catt KJ; Dufau ML; Vaitukaitis JL
    J Clin Endocrinol Metab; 1975 Mar; 40(3):537-40. PubMed ID: 1117063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disappearance of human chorionic gonadotropin and resumption of ovulation following abortion.
    Marrs RP; Kletzky OA; Howard WF; Mishell DR
    Am J Obstet Gynecol; 1979 Nov; 135(6):731-6. PubMed ID: 495673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radioimmunological and serological assay of urinary excretion of the luteinizing hormone in women with amenorrhea].
    Szymański W
    Ginekol Pol; 1975 Jan; 46(1):57-61. PubMed ID: 1110028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Embryonic development and blastocyst implantation following in vitro fertilization and embryo transfer.
    Lopata A; Martin M; Oliva K; Johnston I
    Fertil Steril; 1982 Dec; 38(6):682-7. PubMed ID: 7141009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of relaxin secretion in nonpregnant women by human chorionic gonadotropin.
    Quagliarello J; Goldsmith L; Steinetz B; Lustig DS; Weiss G
    J Clin Endocrinol Metab; 1980 Jul; 51(1):74-7. PubMed ID: 7380995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study.
    European Recombinant LH Study Group
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2607-18. PubMed ID: 11397861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human chorionic gonadotrophin (hCG) in IUD users.
    Dhont M; Thiery M; Vanlancker M
    IRCS J Med Sci; 1984 Sep; 12(9):862. PubMed ID: 12340100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary human chorionic gonadotropin among intrauterine device users: detection with a highly specific and sensitive assay.
    Wilcox AJ; Weinberg CR; Armstrong EG; Canfield RE
    Fertil Steril; 1987 Feb; 47(2):265-9. PubMed ID: 3817172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verification of early pregnancy tests in a multicenter trial.
    Jovanovic L; Singh M; Saxena BB; Mills JL; Tulchinsky D; Holmes LB; Simpson JL; Metzger BE; Labarbera A; Aarons J
    Proc Soc Exp Biol Med; 1987 Feb; 184(2):201-5. PubMed ID: 3809174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentrations of human chorionic gonadotropin from the time of implantation until the second week of pregnancy.
    Lenton EA; Neal LM; Sulaiman R
    Fertil Steril; 1982 Jun; 37(6):773-8. PubMed ID: 7115557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of circulating chorionic gonadotropin in wearers of intrauterine contraceptive devices.
    Klein TA; Mishell DR
    Am J Obstet Gynecol; 1977 Nov; 129(6):626-8. PubMed ID: 920763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of human chorionic gonadotropin in blood of regularly bleeding women using copper intrauterine contraceptive devices.
    Landesman R; Coutinho EM; Saxena BB
    Fertil Steril; 1976 Sep; 27(9):1062-6. PubMed ID: 964399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery of preimplantation blastocysts in the squirrel monkey by a laparoscopic technique.
    Ariga S; Dukelow WR
    Fertil Steril; 1977 May; 28(5):577-80. PubMed ID: 140077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy-specific beta 1-glycoprotein and chorionic gonadotropin-like immunoreactivity during the latter half of the cycle in women using intrauterine contraception.
    Seppälä M; Rutanen EM; Jalanko H; Lehtovirta P; Stenman UH; Engvall E
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1216-9. PubMed ID: 318094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chorionic gonadotropin in women fitted with intrauterine device.
    Yarkoni S; Zer TA; Schenker JG
    Infertility; 1980; 3(1):23-7. PubMed ID: 12263338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of human chorionic gonadotropin in normal and abnormal pregnancies.
    Ho HH; O'Connor JF; Nakajima ST; Tieu J; Overstreet JW; Lasley BL
    Early Pregnancy; 1997 Sep; 3(3):213-24. PubMed ID: 10086072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chorionic gonadotropin receptors and immunoreactive chorionic gonadotropin in implantation of the rabbit blastocyst.
    Khan-Dawood FS; Dawood MY
    Am J Obstet Gynecol; 1984 Feb; 148(4):359-65. PubMed ID: 6320644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Regulation of fertility by anti-hCG vaccines].
    Frydman R; Bellet D
    Contracept Fertil Sex (Paris); 1987 Sep; 15(9):817-20. PubMed ID: 12281242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma LH-HCG, 17 -estradiol, estrone and progesterone monitoring around ovulation and subsequent nidation.
    Thomas K; De Hertogh R; Pizarro M; Van Exter C; Ferin J
    Int J Fertil; 1973; 18(2):65-73. PubMed ID: 4353919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of methods for the prospective identification of early fetal losses in environmental epidemiology studies.
    Sweeney AM; Meyer MR; Aarons JH; Mills JL; LaPorte RE
    Am J Epidemiol; 1988 Apr; 127(4):843-50. PubMed ID: 3354549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.